Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells

Xiangshan Zhao, Gautam K. Malhotra, Hamid Band, Vimla Band

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5 +/K19 - type, and a K5 +/K19 + type. Under specific culture conditions, bipotent K5 +/K19 - stem/progenitor cells differentiated into stable clonal populations that were K5 -/K19 - and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5 +/K19 - cells which are bipotent. These K5 -/K19 - cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.

Original languageEnglish (US)
Article numbere35338
JournalPloS one
Volume7
Issue number4
DOIs
StatePublished - Apr 13 2012

Fingerprint

Stem cells
breasts
stem cells
Breast
Stem Cells
breast neoplasms
Breast Neoplasms
Microarrays
Cell culture
Epithelial-Mesenchymal Transition
Availability
Population Dynamics
cells
cell lines
Cell Line
neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Cite this

Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells. / Zhao, Xiangshan; Malhotra, Gautam K.; Band, Hamid; Band, Vimla.

In: PloS one, Vol. 7, No. 4, e35338, 13.04.2012.

Research output: Contribution to journalArticle

@article{2756e7e6a76943a386d17e79c69961a0,
title = "Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells",
abstract = "There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5 +/K19 - type, and a K5 +/K19 + type. Under specific culture conditions, bipotent K5 +/K19 - stem/progenitor cells differentiated into stable clonal populations that were K5 -/K19 - and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5 +/K19 - cells which are bipotent. These K5 -/K19 - cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.",
author = "Xiangshan Zhao and Malhotra, {Gautam K.} and Hamid Band and Vimla Band",
year = "2012",
month = "4",
day = "13",
doi = "10.1371/journal.pone.0035338",
language = "English (US)",
volume = "7",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Derivation of myoepithelial progenitor cells from bipotent mammary stem/progenitor cells

AU - Zhao, Xiangshan

AU - Malhotra, Gautam K.

AU - Band, Hamid

AU - Band, Vimla

PY - 2012/4/13

Y1 - 2012/4/13

N2 - There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5 +/K19 - type, and a K5 +/K19 + type. Under specific culture conditions, bipotent K5 +/K19 - stem/progenitor cells differentiated into stable clonal populations that were K5 -/K19 - and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5 +/K19 - cells which are bipotent. These K5 -/K19 - cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.

AB - There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5 +/K19 - type, and a K5 +/K19 + type. Under specific culture conditions, bipotent K5 +/K19 - stem/progenitor cells differentiated into stable clonal populations that were K5 -/K19 - and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5 +/K19 - cells which are bipotent. These K5 -/K19 - cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.

UR - http://www.scopus.com/inward/record.url?scp=84859717337&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859717337&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0035338

DO - 10.1371/journal.pone.0035338

M3 - Article

C2 - 22514728

AN - SCOPUS:84859717337

VL - 7

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 4

M1 - e35338

ER -